Almenciol, Fe C.

HRN: 02 65 00  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/24/2022
12/30/2022
IV
600mg
Q8
Soft Tissue Infection
Waiting Final Action 
01/01/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
01/01/2023
01/07/2023
IVT
750 Mg
OD
Cap-mr; Infected Wound , R Breast; Breast Ca
Waiting Final Action 
01/01/2023
CEFTAZIDIME 1GM (VIAL)
01/01/2023
01/07/2023
IVT
2 G
Q8h
Cap-mr; Infected Wound , R Breast; Breast Ca
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: